U.S. Illnesses and Deaths Associated With Compounded Medications or Repackaged Medications

2001-2013

U.S. Illnesses and Deaths Associated With Compounded Medications, 2001-2013

Note: Please click here for the most recent data on adverse events associated with compounded drugs.

The table below was updated on Nov. 19, 2015, to reflect newly reported events, but is no longer current.

RXP_compounds_km_RF
RXP_compounds_km_RF
Data Visualization

U.S. Illnesses and Deaths Tied to Compounded or Repackaged Medications

Quick View
Data Visualization

Pew’s drug safety project has identified 73 reported compounding errors or potential errors associated with more than 1,562 adverse events, including at least 116 deaths, from 2001 to 2019. However, a 2015 survey found that only 30 percent of states (13 of the 43 that responded) require sterile compounding pharmacies to report serious adverse events.

Pew’s drug safety project has identified over 25 reported compounding errors or potential errors associated with 1,076 adverse events, including 90 deaths, since 2001. Because many such events may go unreported this list is probably an underestimation. Contamination of sterile products was the most common error, though others were the result of pharmacists’ and technicians’ miscalculations and mistakes in filling prescriptions.

Download the chart (PDF)

The front facade of the Supreme Court of the United States in Washington, DC.
ian-hutchinson-U8WfiRpsQ7Y-unsplash.jpg_master

Agenda for America

Resources for federal, state, and local decision-makers

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest.